Myeloproliferative disorders are a group of slow-growing blood cancers, including chronic myelogenous leukemia, in which large numbers of abnormal red blood cells, white blood cells, or platelets grow and spread in the bone marrow and the peripheral blood.
The following PDQ treatment summaries are available:
| Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Includes childhood myelodysplastic syndromes and other myeloproliferative disorders. [ patients ] [ health professionals ] | ||||
| Acute Myeloid Leukemia [ patients ] [ health professionals ] | ||||
| Chronic Myelogenous Leukemia [ patients ] [ health professionals ] | ||||
| Chronic Myeloproliferative Disorders [ patients ] [ health professionals ] | ||||
| ||||
| Myelodysplastic Syndromes Includes refractory anemia, refractory anemia with excess blasts, refractory anemia with ringed sideroblasts, refractory cytopenia with multilineage dysplasia, unclassifiable myelodysplastic syndrome, and myelodysplastic syndrome associated with del (5q). [ patients ] [ health professionals ] | ||||
| ||||
| Myelodysplastic/Myeloproliferative Neoplasms [ patients ] [ health professionals ] | ||||
|
